Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor
Theodora Fifis, Linh Nguyen, Cathy Malcontenti-Wilson, Lie Sam Chan, Patricia Luiza Nunes Costa, Jurstine Daruwalla, Mehrdad Nikfarjam, Vijayaragavan Muralidharan, Mark Waltham, Erik W Thompson, Christopher Christophi
Cancer Medicine | WILEY-BLACKWELL | Published : 2013
Awarded by National Health and Medical Research Council (NHMRC) of Australia
This work was supported by funds obtained from the National Health and Medical Research Council (NHMRC) of Australia, project grant number 400190, the Austin Medical Research Fund and in part by the Victorian Government's OIS Program. L. N. and L. C. were supported by postgraduate research scholarships from Australian Rotary Health.